A study of genetic characteristics and suitability for targeted cancer treatment (TARGET)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

All cancer types, Secondary cancers

Status:

Closed

Phase:

Other

Details

This study is looking at gene changes in advanced solid cancers and how genetic information can help doctors decide the most suitable phase 1 trial for people to take part in.

A solid tumour is any type of cancer apart from those of the blood system or lymphatic system such as leukaemia or lymphoma.

Recruitment start: 23 April 2015

Recruitment end: 2 February 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Matthew Krebs

Supported by

Cancer Research UK Manchester Institute

Experimental Cancer Medicine Centre (ECMC)

Manchester Centre for Genomic Medicine

Manchester Cancer Research Centre (MCRC)

The Christie NHS Foundation Trust

Last reviewed: 15 September 2024

CRUK internal database number: 14693

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.